Characterization of Rotavirus RNAs That Activate Innate Immune Signaling through the RIG-I-Like Receptors

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Uzri, Dina ^a,b   Greenberg, Harry B ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; INTERFERON; MDA5 PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; RETINOIC ACID INDUCIBLE PROTEIN I RECEPTOR; SINGLE STRANDED RNA; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; EMBRYO; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; INNATE IMMUNITY; INTERFERON INDUCTION; MOUSE; MOUSE EMBRYO; NONHUMAN; RNA ANALYSIS; RNA ISOLATION; RNA STRUCTURE; ROTAVIRUS; ROTAVIRUS INFECTION; SIGNAL TRANSDUCTION; VIRUS PARTICLE; VIRUS PURIFICATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN MAPPING; CASE-CONTROL STUDIES; CELL PHYSIOLOGICAL PHENOMENA; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GLUCOSE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEURAL NETWORKS (COMPUTER); NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY;

EID: 84880707570     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069825     Document Type: Article

References (78)

1. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI, (2003) Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9: 565-572. doi:10.3201/eid0905.020562. PubMed: 12737740.
2. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, et al. (2012) 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 12: 136-141. doi:10.1016/S1473-3099(11)70253-5. PubMed: 22030330.
3. Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, et al. (2011) Real-world impact of rotavirus vaccination. Pediatr Infect Dis J 30: S1-S5. doi:10.1097/INF.0b013e3181fefa1f. PubMed: 21183833.
4. Gerna G, Sarasini A, Di Matteo A, Zentilin L, Miranda P, et al. (1990) Serotype 3 human rotavirus strains with subgroup I specificity. J Clin Microbiol 28: 1342-1347. PubMed: 2166081.
5. Nakagomi O, Ohshima A, Aboudy Y, Shif I, Mochizuki M, et al. (1990) Molecular identification by RNA-RNA hybridization of a human rotavirus that is closely related to rotaviruses of feline and canine origin. J Clin Microbiol 28: 1198-1203. PubMed: 2166076.
6. Estes MK, Kapikian AZ, (2007) Rotaviruses. In: Knipe DM, Howley PM, eds. Fields Virology. fifth ed. Philadelphia: Lippincott Williams & Wilkins. pp. pp. 1917-1974.
7. Randall RE, Goodbourn S, (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89: 1-47. doi:10.1099/vir.0.83391-0. PubMed: 18089727.
8. Schoggins JW, Rice CM, (2011) Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 1: 519-525. doi:10.1016/j.coviro.2011.10.008. PubMed: 22328912.
9. Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA, (2011) Pattern recognition receptors and the innate immune response to viral infection. Viruses 3: 920-940. doi:10.3390/v3060920. PubMed: 21994762.
10. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, et al. (2005) Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175: 2851-2858. PubMed: 16116171.
11. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, et al. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5: 730-737. doi:10.1038/ni1087. PubMed: 15208624.
12. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, et al. (2006) 5'-Triphosphate RNA is the ligand for RIG-I. Science 314: 994-997. doi:10.1126/science.1132505. PubMed: 17038590.
13. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 314: 997-1001. doi:10.1126/science.1132998. PubMed: 17038589.
14. Plumet S, Herschke F, Bourhis JM, Valentin H, Longhi S, et al. (2007) Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLOS ONE 2: e279. doi:10.1371/journal.pone.0000279. PubMed: 17356690.
15. Rehwinkel J, Tan CP, Goubau D, Schulz O, Pichlmair A, et al. (2010) RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140: 397-408. doi:10.1016/j.cell.2010.01.020. PubMed: 20144762.
16. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M Jr., (2008) Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454: 523-527. doi:10.1038/nature07106. PubMed: 18548002.
17. Uzri D, Gehrke L, (2009) Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities. J Virol 83: 4174-4184. doi:10.1128/JVI.02449-08. PubMed: 19224987.
18. Schlee M, Roth A, Hornung V, Hagmann CA, Wimmenauer V, et al. (2009) Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31: 25-34. doi:10.1016/j.immuni.2009.05.008. PubMed: 19576794.
19. Schmidt A, Schwerd T, Hamm W, Hellmuth JC, Cui S, et al. (2009) 5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci U S A 106: 12067-12072. doi:10.1073/pnas.0900971106. PubMed: 19574455.
20. Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, et al. (2008) Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205: 1601-1610. doi:10.1084/jem.20080091. PubMed: 18591409.
21. Marques JT, Devosse T, Wang D, Zamanian-Daryoush M, Serbinowski P, et al. (2006) A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol 24: 559-565. doi:10.1038/nbt1205. PubMed: 16648842.
22. Malathi K, Dong B, Gale M Jr., Silverman RH, (2007) Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: 816-819. doi:10.1038/nature06042. PubMed: 17653195.
23. Pichlmair A, Schulz O, Tan CP, Rehwinkel J, Kato H, et al. (2009) Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol 83: 10761-10769. doi:10.1128/JVI.00770-09. PubMed: 19656871.
24. Zust R, Cervantes-Barragan L, Habjan M, Maier R, Neuman BW, et al. (2011) Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol 12: 137-143. doi:10.1038/nrm3071. PubMed: 21217758.
25. Bamming D, Horvath CM, (2009) Regulation of signal transduction by enzymatically inactive antiviral RNA helicase proteins MDA5, RIG-I, and LGP2. J Biol Chem 284: 9700-9712. doi:10.1074/jbc.M807365200. PubMed: 19211564.
26. Cui S, Eisenacher K, Kirchhofer A, Brzozka K, Lammens A, et al. (2008) The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol Cell 29: 169-179. doi:10.1016/j.molcel.2007.10.032. PubMed: 18243112.
27. Saito T, Hirai R, Loo YM, Owen D, Johnson CL, et al. (2007) Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A 104: 582-587. doi:10.1073/pnas.0606699104. PubMed: 17190814.
28. Takahasi K, Yoneyama M, Nishihori T, Hirai R, Kumeta H, et al. (2008) Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell 29: 428-440. doi:10.1016/j.molcel.2007.11.028. PubMed: 18242112.
29. Gack MU, Kirchhofer A, Shin YC, Inn KS, Liang C, et al. (2008) Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc Natl Acad Sci U S A 105: 16743-16748. doi:10.1073/pnas.0804947105. PubMed: 18948594.
30. Gack MU, Shin YC, Joo CH, Urano T, Liang C, et al. (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446: 916-920. doi:10.1038/nature05732. PubMed: 17392790.
31. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, et al. (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6: 981-988. doi:10.1038/ni1243. PubMed: 16127453.
32. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172. doi:10.1038/nature04193. PubMed: 16177806.
33. Seth RB, Sun L, Ea CK, Chen ZJ, (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682. doi:10.1016/j.cell.2005.08.012. PubMed: 16125763.
34. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, et al. (2005) VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19: 727-740. doi:10.1016/j.molcel.2005.08.014. PubMed: 16153868.
35. Franco MA, Feng N, Greenberg HB, (1996) Rotavirus immunity in the mouse. Arch Virol Suppl 12: 141-152. PubMed: 9015111.
36. McNeal MM, VanCott JL, Choi AH, Basu M, Flint JA, et al. (2002) CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G). J Virol 76: 560-568. doi:10.1128/JVI.76.2.560-568.2002. PubMed: 11752147.
37. Arnold MM, Patton JT, (2011) Diversity of interferon antagonist activities mediated by NSP1 proteins of different rotavirus strains. J Virol 85: 1970-1979. doi:10.1128/JVI.01801-10. PubMed: 21177809.
38. Barro M, Patton JT, (2005) Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc Natl Acad Sci U S A 102: 4114-4119. doi:10.1073/pnas.0408376102. PubMed: 15741273.
39. Barro M, Patton JT, (2007) Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7. J Virol 81: 4473-4481. doi:10.1128/JVI.02498-06. PubMed: 17301153.
40. Feng N, Sen A, Nguyen H, Vo P, Hoshino Y, et al. (2009) Variation in antagonism of the interferon response to rotavirus NSP1 results in differential infectivity in mouse embryonic fibroblasts. J Virol 83: 6987-6994. doi:10.1128/JVI.00585-09. PubMed: 19420080.
41. Graff JW, Ettayebi K, Hardy ME, (2009) Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism. PLOS Pathog 5: e1000280.
42. Graff JW, Ewen J, Ettayebi K, Hardy ME, (2007) Zinc-binding domain of rotavirus NSP1 is required for proteasome-dependent degradation of IRF3 and autoregulatory NSP1 stability. J Gen Virol 88: 613-620. doi:10.1099/vir.0.82255-0. PubMed: 17251580.
43. Sen A, Feng N, Ettayebi K, Hardy ME, Greenberg HB, (2009) IRF3 inhibition by rotavirus NSP1 is host cell and virus strain dependent but independent of NSP1 proteasomal degradation. J Virol 83: 10322-10335. doi:10.1128/JVI.01186-09. PubMed: 19656876.
44. Deal EM, Jaimes MC, Crawford SE, Estes MK, Greenberg HB, (2010) Rotavirus structural proteins and dsRNA are required for the human primary plasmacytoid dendritic cell IFNalpha response. PLOS Pathog 6: e1000931.
45. Sen A, Pruijssers AJ, Dermody TS, Garcia-Sastre A, Greenberg HB, (2011) The early interferon response to rotavirus is regulated by PKR and depends on MAVS/IPS-1, RIG-I, MDA-5, and IRF3. J Virol 85: 3717-3732. doi:10.1128/JVI.02634-10. PubMed: 21307186.
46. Broquet AH, Hirata Y, McAllister CS, Kagnoff MF, (2011) RIG-I/MDA5/MAVS are required to signal a protective IFN response in rotavirus-infected intestinal epithelium. J Immunol 186: 1618-1626. doi:10.4049/jimmunol.1002862. PubMed: 21187438.
47. Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, et al. (2008) Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82: 335-345. doi:10.1128/JVI.01080-07. PubMed: 17942531.
48. Stacy-Phipps S, Patton JT, (1987) Synthesis of plus- and minus-strand RNA in rotavirus-infected cells. J Virol 61: 3479-3484. PubMed: 2822955.
49. Silvestri LS, Taraporewala ZF, Patton JT, (2004) Rotavirus replication: plus-sense templates for double-stranded RNA synthesis are made in viroplasms. J Virol 78: 7763-7774. doi:10.1128/JVI.78.14.7763-7774.2004. PubMed: 15220450.
50. Furuichi Y, Muthukrishnan S, Tomasz J, Shatkin AJ, (1976) Mechanism of formation of reovirus mRNA 5'-terminal blocked and methylated sequence, m7GpppGmpC. J Biol Chem 251: 5043-5053. PubMed: 821947.
51. Lawton JA, Estes MK, Prasad BV, (1999) Comparative structural analysis of transcriptionally competent and incompetent rotavirus-antibody complexes. Proc Natl Acad Sci U S A 96: 5428-5433. doi:10.1073/pnas.96.10.5428. PubMed: 10318900.
52. Yamakawa M, Furuichi Y, Nakashima K, LaFiandra AJ, Shatkin AJ, (1981) Excess synthesis of viral mRNA 5-terminal oligonucleotides by reovirus transcriptase. J Biol Chem 256: 6507-6514. PubMed: 7240222.
53. Rojas M, Arias CF, Lopez S, (2010) Protein kinase R is responsible for the phosphorylation of eIF2alpha in rotavirus infection. J Virol 84: 10457-10466. doi:10.1128/JVI.00625-10. PubMed: 20631127.
54. Schonborn J, Oberstrass J, Breyel E, Tittgen J, Schumacher J, et al. (1991) Monoclonal antibodies to double-stranded RNA as probes of RNA structure in crude nucleic acid extracts. Nucleic Acids Res 19: 2993-3000. doi:10.1093/nar/19.11.2993. PubMed: 2057357.
55. Boyce M, Roy P, (2007) Recovery of infectious bluetongue virus from RNA. J Virol 81: 2179-2186. doi:10.1128/JVI.01819-06. PubMed: 17151117.
56. Imai M, Akatani K, Ikegami N, Furuichi Y, (1983) Capped and conserved terminal structures in human rotavirus genome double-stranded RNA segments. J Virol 47: 125-136. PubMed: 6306269.
57. Holloway G, Coulson BS, (2013) Innate cellular responses to rotavirus infection. J Gen Virol 94: 1151-1160. doi:10.1099/vir.0.051276-0. PubMed: 23486667.
58. Arnold MM, Sen A, Greenberg HB, Patton JT, (2013) The battle between rotavirus and its host for control of the interferon signaling pathway. PLOS Pathog 9: e1003064.
59. Ghosh A, Lima CD, (2010) Enzymology of RNA cap synthesis. Wiley Interdiscip Rev RNA 1: 152-172. PubMed: 21956912.
60. Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, et al. (2010) 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468: 452-456. doi:10.1038/nature09489. PubMed: 21085181.
61. Qin L, Ren L, Zhou Z, Lei X, Chen L, et al. (2011) Rotavirus nonstructural protein 1 antagonizes innate immune response by interacting with retinoic acid inducible gene I. Virol J 8: 526. doi:10.1186/1743-422X-8-526. PubMed: 22152002.
62. Holloway G, Truong TT, Coulson BS, (2009) Rotavirus antagonizes cellular antiviral responses by inhibiting the nuclear accumulation of STAT1, STAT2, and NF-kappaB. J Virol 83: 4942-4951. doi:10.1128/JVI.01450-08. PubMed: 19244315.
63. Broome RL, Vo PT, Ward RL, Clark HF, Greenberg HB, (1993) Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence. J Virol 67: 2448-2455. PubMed: 8386262.
64. Feng N, Kim B, Fenaux M, Nguyen H, Vo P, et al. (2008) Role of interferon in homologous and heterologous rotavirus infection in the intestines and extraintestinal organs of suckling mice. J Virol 82: 7578-7590. doi:10.1128/JVI.00391-08. PubMed: 18495762.
65. Feng N, Yasukawa LL, Sen A, Greenberg HB, (2013) Permissive replication of homologous murine rotavirus in the mouse intestine is primarily regulated by VP4 and NSP1. J Virol (In press).
66. Hoshino Y, Saif LJ, Kang SY, Sereno MM, Chen WK, et al. (1995) Identification of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus in the gnotobiotic piglet model. Virology 209: 274-280. doi:10.1006/viro.1995.1255. PubMed: 7747480.
67. Chen D, Patton JT, (1998) Rotavirus RNA replication requires a single-stranded 3' end for efficient minus-strand synthesis. J Virol 72: 7387-7396. PubMed: 9696835.
68. Li W, Manktelow E, von Kirchbach JC, Gog JR, Desselberger U, et al. (2010) Genomic analysis of codon, sequence and structural conservation with selective biochemical-structure mapping reveals highly conserved and dynamic structures in rotavirus RNAs with potential cis-acting functions. Nucleic Acids Res 38: 7718-7735. doi:10.1093/nar/gkq663. PubMed: 20671030.
69. Tortorici MA, Shapiro BA, Patton JT, (2006) A base-specific recognition signal in the 5' consensus sequence of rotavirus plus-strand RNAs promotes replication of the double-stranded RNA genome segments. RNA 12: 133-146. doi:10.1261/rna.2122606. PubMed: 16301600.
70. Pott J, Stockinger S, Torow N, Smoczek A, Lindner C, et al. (2012) Age-dependent TLR3 expression of the intestinal epithelium contributes to rotavirus susceptibility. PLOS Pathog 8: e1002670.
71. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J, (1982) Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42: 3858-3863. PubMed: 6286115.
72. Blight KJ, McKeating JA, Rice CM, (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76: 13001-13014. doi:10.1128/JVI.76.24.13001-13014.2002. PubMed: 12438626.
73. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, et al. (2005) Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19-28. doi:10.1016/j.immuni.2005.04.010. PubMed: 16039576.
74. Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, et al. (2006) Essential role of mda-5 in type I IFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 103: 8459-8464. doi:10.1073/pnas.0603082103. PubMed: 16714379.
75. Sun Q, Sun L, Liu HH, Chen X, Seth RB, et al. (2006) The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24: 633-642. doi:10.1016/j.immuni.2006.04.004. PubMed: 16713980.
76. Hoshino Y, Wyatt RG, Greenberg HB, Flores J, Kapikian AZ, (1984) Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis 149: 694-702. doi:10.1093/infdis/149.5.694. PubMed: 6202807.
77. Bridger JC, Woode GN, (1976) Characterization of two particle types of calf rotavirus. J Gen Virol 31: 245-250. doi:10.1099/0022-1317-31-2-245. PubMed: 180243.
78. Cohen J, (1977) Ribonucleic acid polymerase activity associated with purified calf rotavirus. J Gen Virol 36: 395-402. doi:10.1099/0022-1317-36-3-395. PubMed: 21225.